Localised intraabdominal fluid collection
(UMLS:C1868693)
- UMLS ID:
- C1868693
- MeSH ID:
- N/A
Synonym(s)
1.
Localised intraabdominal fluid collection
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Octreotide | FAERS: 22 | US FAERS | |
| 2 | Norgestrel | FAERS: 7 | US FAERS | |
| 3 | Baclofen | FAERS: 6 | OFFSIDES US FAERS | |
| 4 | Everolimus | FAERS: 6 | SIDER US FAERS | |
| 5 | Sitagliptin Phosphate | FAERS: 6 | US FAERS | |
| 6 | Bosentan | FAERS: 4 | US FAERS | |
| 7 | ambrisentan | FAERS: 4 | OFFSIDES US FAERS | |
| 8 | Ceftriaxone | FAERS: 3 | US FAERS | |
| 9 | Clozapine | FAERS: 3 | OFFSIDES US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 3 | US FAERS | |
| 11 | NuvaRing | FAERS: 3 | US FAERS | |
| 12 | ledipasvir, sofosbuvir drug combination | FAERS: 3 | US FAERS | |
| 13 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 | US FAERS | |
| 14 | Citalopram | FAERS: 2 | US FAERS | |
| 15 | Tacrolimus | FAERS: 2 | US FAERS | |
| 16 | Testosterone | FAERS: 2 | US FAERS | |
| 17 | Varenicline | FAERS: 2 | US FAERS | |
| 18 | carbidopa, levodopa drug combination | FAERS: 2 | US FAERS | |
| 19 | teriflunomide | FAERS: 2 | US FAERS | |
| 20 | Amlodipine | FAERS: 1 | US FAERS | |
| 21 | Atorvastatin | FAERS: 1 | US FAERS | |
| 22 | Carvedilol | FAERS: 1 | US FAERS | |
| 23 | Cinacalcet | FAERS: 1 | US FAERS | |
| 24 | Copper | FAERS: 1 | US FAERS | |
| 25 | Cyclosporine | FAERS: 1 | US FAERS | |
| 26 | Dasatinib | FAERS: 1 | US FAERS | |
| 27 | Deferasirox | FAERS: 1 | US FAERS | |
| 28 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 29 | Epoprostenol | FAERS: 1 | US FAERS | |
| 30 | Exenatide | FAERS: 1 | US FAERS | |
| 31 | Gentamicins | FAERS: 1 | US FAERS | |
| 32 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 33 | LCZ 696 | FAERS: 1 | US FAERS | |
| 34 | Latanoprost | FAERS: 1 | US FAERS | |
| 35 | Methylprednisolone | FAERS: 1 | US FAERS | |
| 36 | Mitomycin | FAERS: 1 | OFFSIDES US FAERS | |
| 37 | Omeprazole | FAERS: 1 | US FAERS | |
| 38 | PCI 32765 | FAERS: 1 | US FAERS | |
| 39 | Paclitaxel | FAERS: 1 | US FAERS | |
| 40 | Pregabalin | FAERS: 1 | US FAERS | |
| 41 | Rifaximin | FAERS: 1 | US FAERS | |
| 42 | Sandostatin LAR Depot | FAERS: 1 | US FAERS | |
| 43 | Senna Extract | FAERS: 1 | US FAERS | |
| 44 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 45 | Sofosbuvir | FAERS: 1 | US FAERS | |
| 46 | Sorafenib | FAERS: 1 | US FAERS | |
| 47 | Sunitinib | FAERS: 1 | US FAERS | |
| 48 | Tadalafil | FAERS: 1 | US FAERS | |
| 49 | Temozolomide | FAERS: 1 | US FAERS | |
| 50 | Valproic Acid | FAERS: 1 | US FAERS | |
| 51 | Valsartan | FAERS: 1 | US FAERS | |
| 52 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 53 | bicalutamide | FAERS: 1 | US FAERS | |
| 54 | ecallantide | FAERS: 1 | US FAERS | |
| 55 | etonogestrel | FAERS: 1 | US FAERS | |
| 56 | gadodiamide | FAERS: 1 | US FAERS | |
| 57 | macitentan | FAERS: 1 | US FAERS | |
| 58 | pasireotide | FAERS: 1 | US FAERS | |
| 59 | ponatinib | FAERS: 1 | US FAERS | |
| 60 | tegaserod | FAERS: 1 | US FAERS | |
| 61 | Amantadine | OFFSIDES | ||
| 62 | Bortezomib | OFFSIDES | ||
| 63 | Cefotaxime | OFFSIDES | ||
| 64 | Chlordiazepoxide | OFFSIDES | ||
| 65 | Donepezil | OFFSIDES | ||
| 66 | Fluorometholone | OFFSIDES | ||
| 67 | Ganciclovir | OFFSIDES | ||
| 68 | Hydroxyurea | OFFSIDES | ||
| 69 | Ketoconazole | OFFSIDES | ||
| 70 | Leucovorin | OFFSIDES | ||
| 71 | Lopinavir/Ritonavir | OFFSIDES | ||
| 72 | Methyldopa | OFFSIDES | ||
| 73 | Metolazone | OFFSIDES | ||
| 74 | Octreotide | OFFSIDES | ||
| 75 | Ribavirin | OFFSIDES | ||
| 76 | Timolol | OFFSIDES | ||
| 77 | Tobramycin | OFFSIDES | ||
| 78 | Urea | OFFSIDES | ||
| 79 | betamethasone butyrate propionate | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.